Can DTDS Be Mistaken for Cerebral Palsy? Understanding the Diagnostic Overlap

When a young child has significant movement difficulties, abnormal muscle tone, dystonia, developmental differences, or difficulty with motor skills, cerebral palsy (CP) may be one of the first diagnoses considered.

For many children, that diagnosis is appropriate. But some rare genetic and neurological disorders can cause symptoms that look similar to cerebral palsy.

Dopamine Transporter Deficiency Syndrome (DTDS) is one of those conditions.

Because DTDS is extremely rare and can resemble other movement disorders, some individuals with DTDS may initially be diagnosed with cerebral palsy or another neurological condition. Understanding where these conditions overlap, and where they differ, can be an important part of the diagnostic journey.

What is cerebral palsy?

Cerebral palsy is a group of disorders that affect movement, muscle tone, posture, and motor development. It results from abnormal development of, or damage to, the developing brain.

The underlying brain disturbance occurs while the brain is developing, although the specific cause may not always be identified.

Cerebral palsy can look very different from one person to another. Some individuals have primarily spasticity, while others may have dystonia, dyskinesia, or other movement differences. Communication, feeding, vision, cognition, and other areas can also be affected.

Because cerebral palsy is a clinical diagnosis with a broad range of presentations, its features can overlap with other neurological and genetic disorders.

Can DTDS be mistaken for cerebral palsy?

Yes. DTDS can cause movement and developmental features that resemble cerebral palsy, particularly in young children.

Children with DTDS may have:

  • Abnormal muscle tone

  • Dystonia

  • Spasticity or other movement differences

  • Difficulty with voluntary movement

  • Delayed motor development

  • Limited mobility

  • Abnormal or unusual movement patterns

  • Feeding or swallowing difficulties

  • Communication difficulties

These features can overlap substantially with the symptoms seen in cerebral palsy.

For a child with a rare disorder like DTDS, the initial diagnosis may therefore focus on the child's physical and developmental presentation rather than the underlying genetic cause.

A diagnosis of cerebral palsy may accurately describe a child's movement and developmental challenges without identifying the underlying cause of those symptoms. However, when the clinical picture does not fully fit, additional diagnostic evaluation may be appropriate.

Can someone have cerebral palsy with a normal MRI?

Yes. A normal brain MRI does not automatically rule out cerebral palsy.

MRI is commonly used when evaluating children with suspected cerebral palsy because it can provide information about the developing brain and may help identify an underlying cause. However, not every person with cerebral palsy has an abnormal MRI.

Some children with cerebral palsy may have normal or nonspecific findings on brain imaging. MRI findings should therefore be interpreted alongside the child's history, examination, development, and other clinical information.

This is important because families may understandably wonder:

If the MRI is normal, does that mean my child cannot have cerebral palsy?

The answer is not necessarily.

At the same time, a normal or nonspecific MRI may be one piece of information that prompts clinicians to consider whether another diagnosis could better explain the child's symptoms, particularly when other aspects of the clinical picture do not fit typical expectations.

When might doctors look beyond a cerebral palsy diagnosis?

There is no single test or symptom that determines when a child should be evaluated for another condition.

However, additional evaluation may be considered when a child's symptoms, development, medical history, examination, or test results do not fully fit the expected clinical picture.

Depending on the individual situation, clinicians may consider:

  • Genetic testing

  • Metabolic or biochemical testing

  • Additional neurological evaluation

  • Review by a movement disorder specialist

  • Additional imaging or other specialized testing

  • Evaluation for a rare genetic or neurodevelopmental disorder

Genetic testing can be particularly important because many rare disorders cannot be identified through brain imaging alone.

How is DTDS different from cerebral palsy?

Although DTDS and cerebral palsy can have overlapping features, they have different underlying causes.

Cerebral palsy results from abnormal development of or damage to the developing brain.

DTDS is a genetic disorder caused by disease-causing variants in both copies of the SLC6A3 gene. These variants disrupt the function of the dopamine transporter, a protein involved in regulating dopamine signaling in the brain.

This distinction is important.

A child with DTDS may have significant movement difficulties, abnormal muscle tone, dystonia, and developmental differences that look similar to cerebral palsy. However, the underlying problem in DTDS is a molecular disorder affecting dopamine transport rather than the type of brain injury or abnormal brain development associated with cerebral palsy.

Brain MRI in DTDS may be normal or show nonspecific findings, which can make the diagnosis more difficult to recognize based on imaging alone.

Why genetic testing can matter

For some families, the search for an explanation can continue long after a child receives an initial diagnosis.

A diagnosis such as cerebral palsy may describe what a child is experiencing, but it may not always explain why those symptoms are occurring.

When a child's presentation is unusual, severe, progressive, unexpected, or not fully explained by the available information, genetic testing may help identify an underlying genetic condition.

For DTDS, diagnosis is established through molecular genetic testing that identifies disease-causing variants in both copies of SLC6A3.

Finding a genetic diagnosis can provide more than a name. It can help families understand the underlying biology of the condition, connect with others who have the same diagnosis, inform medical care, and provide opportunities to participate in research.

The diagnostic journey can take time

Rare diseases are often difficult to recognize because physicians may encounter only a small number, or even no other, patients with the same condition during their careers.

For families, that can mean years of appointments, testing, changing diagnoses, and unanswered questions.

DTDS is an ultra-rare disorder, with approximately 50 documented cases worldwide. Its rarity makes awareness particularly important.

A child does not need to have every feature associated with DTDS to warrant consideration of a genetic diagnosis. Likewise, having a cerebral palsy diagnosis does not automatically mean that the diagnosis is incorrect.

The goal is not to replace one diagnosis with another without evidence.

The goal is to understand the child as completely as possible and identify the underlying cause when one can be found.

What should families do if they still have questions?

If you are questioning a child's diagnosis, bring those concerns to the child's healthcare team. Ask whether the child's clinical features are fully explained by the current diagnosis and whether additional evaluation may be appropriate.

Depending on the circumstances, a neurologist, movement disorder specialist, clinical geneticist, or genetic counselor may be able to help determine whether genetic testing or other specialized evaluation should be considered.

Families can also keep a record of:

  • Changes in symptoms or movement patterns over time

  • Developmental milestones

  • Previous diagnoses

  • Genetic and other test results

  • Brain imaging reports

  • Medication responses

  • Feeding, communication, and mobility changes

  • Questions or concerns that arise between appointments

These details can help clinicians see the broader clinical picture.

A diagnosis can open the door to answers

For families navigating a diagnostic odyssey, continuing to ask questions does not mean questioning every diagnosis or assuming that a rare disease is the answer.

Sometimes it simply means recognizing that the whole picture deserves another look.

For families ultimately diagnosed with DTDS, receiving a genetic diagnosis can connect years of symptoms and unanswered questions to a specific biological cause. It can also connect families to a community of people who understand what they are experiencing and to researchers working to better understand the disease.

If your child has been diagnosed with cerebral palsy but the clinical picture does not fully make sense, talk with your healthcare team about whether additional diagnostic evaluation may be appropriate.

Rare diseases can be difficult to recognize. Sometimes, finding the answer begins with asking one more question.

Learn More About DTDS

Dopamine Transporter Deficiency Syndrome (DTDS) is an ultra-rare genetic disorder caused by disease-causing variants in both copies of the SLC6A3 gene.

The DTDS Foundation provides resources for families, healthcare professionals, researchers, and others seeking to learn more about DTDS.

Explore our Understanding DTDS: A Medical & Scientific Glossary to learn more about genetic, neurological, medical, therapeutic, and research terminology related to DTDS.

Next
Next

Understanding DTDS: A Medical & Scientific Glossary